Similar articles

• Pharmaceuticals and medical devices: Medicare Part D.

  Health Policy Tracking Service, a service of Thomson Reuters Accelus; Steiner DJ. Health Policy Tracking Service, a service of Thomson Reuters Accelus, et al. Issue Brief Health Policy Track Serv. 2012 Jan 3:1-37. Issue Brief Health Policy Track Serv. 2012. PMID: 22403844 No abstract available.
• Pharmaceuticals and medical devices: Medicare Part D. End-of-year issue brief.

  Chaps NA. Chaps NA. Issue Brief Health Policy Track Serv. 2009 Jan 5:1-26. Issue Brief Health Policy Track Serv. 2009. PMID: 19301435 No abstract available.
• Pharmaceuticals and medical devices: Medicare Part D. End-of-year issue brief.

  Chaps NA. Chaps NA. Issue Brief Health Policy Track Serv. 2008 Jan 7:1-23. Issue Brief Health Policy Track Serv. 2008. PMID: 18345558 No abstract available.
• Increasing generic drug use in Medicare Part D: the role of government.

  Kohl H, Shrank WH. Kohl H, et al. J Am Geriatr Soc. 2007 Jul;55(7):1106-9. doi: 10.1111/j.1532-5415.2007.01286.x. J Am Geriatr Soc. 2007. PMID: 17608887 Review. No abstract available.
• What is fair? Choice, fairness, and transparency in access to prescription medicines in the United States and Australia.

  Lopert R, Rosenbaum S. Lopert R, et al. J Law Med Ethics. 2007 Winter;35(4):643-56, 512-3. doi: 10.1111/j.1748-720X.2007.00187.x. J Law Med Ethics. 2007. PMID: 18076515 Review.